Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

598
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
598
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.7K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.7K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

1.8K
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
1.8K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.1K
Hand hygiene01:23

Hand hygiene

6.4K
Asepsis is the practice of preventing or breaking the chain of infection. The nurse employs aseptic techniques to prevent the spread of microorganisms and reduce the risk of diseases. Hand hygiene is the cornerstone of aseptic techniques and is classified into medical and surgical asepsis. Medical asepsis includes hand hygiene and the use of gloves. Surgical asepsis, or the sterile technique, refers to practices that render and keep objects and areas free of microorganisms.
Hand washing...
6.4K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Application of AI in Cancer MDT and its Legal Implication.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same author

Evidence for the holocrine nature of lipoid secretion by avian epidermal cells: A histochemical and fine structural study of rictus and the uropygial gland.

Journal of morphology·2018
Same author

CUTANEOUS VASCULITIS.

Medical journal, Armed Forces India·2017
Same author

DERMATOLOGICAL PROBLEMS IN NATIVE HIGHLANDERS OF LADAKH.

Medical journal, Armed Forces India·2017
Same author

DERMATOPHYTOSIS AND DERMATOMYCOSIS IN PUNE.

Medical journal, Armed Forces India·2017
Same author

CHANGING TRENDS OF LEPROSY IN ARMED FORCES.

Medical journal, Armed Forces India·2017

Related Experiment Video

Updated: Mar 8, 2026

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
05:05

Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

Published on: June 17, 2025

1.4K

Multidrug Therapy in Pemphigus Vulgaris.

S P Chattopadhyay, P N Arora, S K Aggarwal

    Indian Journal of Dermatology, Venereology and Leprology
    |February 2, 2017
    PubMed
    Summary

    This study shows that a combination therapy of oral prednisolone, cyclophosphamide, and methotrexate effectively treats pemphigus vulgaris, leading to rapid lesion recovery with minimal side effects in patients.

    Area of Science:

    • Dermatology
    • Immunology
    • Pharmacology

    Background:

    • Pemphigus vulgaris is a chronic autoimmune blistering disease.
    • Current treatments can have significant side effects.
    • Novel therapeutic strategies are needed.

    Purpose of the Study:

    • To evaluate the efficacy and safety of a combined drug therapy for pemphigus vulgaris.
    • To assess the treatment response and side effect profile of the combined regimen.

    Main Methods:

    • Twenty-four patients with pemphigus vulgaris received combined therapy.
    • Regimen included oral prednisolone, cyclophosphamide, and biweekly methotrexate.
    • Dosages were gradually tapered over a 2-year observation period.

    Main Results:

    More Related Videos

    Granulocyte-dependent Autoantibody-induced Skin Blistering
    12:23

    Granulocyte-dependent Autoantibody-induced Skin Blistering

    Published on: October 12, 2012

    10.9K
    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    39.6K

    Related Experiment Videos

    Last Updated: Mar 8, 2026

    Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid
    05:05

    Technique of Conjunctival Biopsy and Direct Immunofluorescence for Diagnosing Mucous Membrane Pemphigoid

    Published on: June 17, 2025

    1.4K
    Granulocyte-dependent Autoantibody-induced Skin Blistering
    12:23

    Granulocyte-dependent Autoantibody-induced Skin Blistering

    Published on: October 12, 2012

    10.9K
    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
    11:39

    The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis

    Published on: July 11, 2013

    39.6K
    • Remarkable treatment response observed with quick recovery from lesions.
    • Two out of twenty-four patients experienced relapse during the observation period.
    • No significant side effects were reported with the combined drug therapy.

    Conclusions:

    • Combined drug therapy offers an effective and safe treatment option for pemphigus vulgaris.
    • This regimen facilitates rapid lesion healing with a favorable safety profile.
    • Further research may explore long-term outcomes and optimal tapering strategies.